glp 1 agonists vs sglt2 inhibitors Criteria for recommendation of or GLP-1 receptor Use of SGLT2 inhibitors and

Avexitide, which has been granted FDA breakthrough therapy designation, has shown significant effectiveness in treating Postbariatric Hypoglycemia (PBH) and congenital hyperinsulinism, and is expected to commence Phase 3 trials for PBH by early 2025

Violett B, Horman S, Leclerc J, et al

Recommended Daily Vitamin D In the US, the current recommended daily dose of vitamin D is 400 IU

It is usually administered in a healthcare setting, such as Neighborhood Medical Center, and the injection is typically given in the muscle (intramuscular, IM) or under the skin (subcutaneously)

Beta M, Khetan V, Chatterjee N, Suganeswari G, Rishi P, Biswas J, et al